Tilray Brands (TLRY) Net Cash Flow Growth (3y) (2022 - 2026)
Tilray Brands (TLRY) Net Cash Flow Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -28.90% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -5.41% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 19.55% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 95.24% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -106.21% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 4.40% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 17.73% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Tilray Brands | 516.11 Mn | 281.48 Mn | 90.52 Mn | -35.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -35.38% |
| Feb 28, 2026 | 27.49% |
| Nov 30, 2025 | 60.51% |
| Aug 31, 2025 | -17.24% |
| May 31, 2025 | -49.70% |
| Feb 28, 2025 | 30.65% |
| Nov 30, 2024 | 33.04% |
| Aug 31, 2024 | 39.68% |
| May 31, 2024 | -34.48% |
| Nov 30, 2023 | 42.39% |
| Aug 31, 2023 | 23.61% |
| May 31, 2023 | -50.44% |
| May 31, 2022 | -20.45% |